Resistance to influenza A virus infection by antigen-conjugated CpG oligonucleotides, a novel antigen-specific immunomodulator.
about
Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone ® in rhesus macaquesBroad-Spectrum Drugs Against Viral AgentsSynthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen.Immunostimulatory DNA as a vaccine adjuvant.Cationic lipid/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone) increases antibody response, cellular immunity, and antigenically drifted protectionGold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza A virus.
P2860
Resistance to influenza A virus infection by antigen-conjugated CpG oligonucleotides, a novel antigen-specific immunomodulator.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Resistance to influenza A viru ...... igen-specific immunomodulator.
@ast
Resistance to influenza A viru ...... igen-specific immunomodulator.
@en
type
label
Resistance to influenza A viru ...... igen-specific immunomodulator.
@ast
Resistance to influenza A viru ...... igen-specific immunomodulator.
@en
prefLabel
Resistance to influenza A viru ...... igen-specific immunomodulator.
@ast
Resistance to influenza A viru ...... igen-specific immunomodulator.
@en
P2093
P1476
Resistance to influenza A viru ...... igen-specific immunomodulator.
@en
P2093
Hiroshi Takaku
Masayuki Fujii
Mayuka Yano
Mieko Hayashi
Naoko Miyano-Kurosaki
Ryouji Ueki
P304
P356
10.1016/J.BBRC.2005.01.116
P407
P577
2005-04-01T00:00:00Z